The first clinical trial in the southern hemisphere for the potential of the COVID-19 vaccine

Dr Nita Patel looks at a computer model showing the protein structure of a potential COVID-19 vaccine at Novavax labs in Maryland

Source: Getty

The first trial of the corona virus vaccine against humans in the southern hemisphere has been launched in Australia. About 130 people aged between 18 and 59 in Melbourne and Brisbane voluntarily participated in the trial


About 10 experimental corona virus vaccines have been tested on people around the world.

And now, the first clinical trial in the southern hemisphere has also begun at Alfred Hospital in Melbourne.

This potential vaccine has been developed by Novavax, a US biopharmaceutical company.


Share

Follow SBS Indonesian

Download our apps

Listen to our podcasts

Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS

SBS Indonesian News

Watch it onDemand

Watch now